According to I-Mab Biopharma's latest financial reports the company's current earnings (TTM) are -HK$80.96 M. In 2022 the company made an earning of -HK$2.83 B an increase over its 2021 earnings that were of -HK$2.85 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.